| DC Field | Value | Language |
|---|
| dc.contributor.author | Katona, Timea | - |
| dc.contributor.author | Budeanu, Razvan-Gabriel | - |
| dc.contributor.author | Jugariu, Anamaria-Romina | - |
| dc.date.accessioned | 2020-07-03T12:23:57Z | - |
| dc.date.available | 2020-07-03T12:23:57Z | - |
| dc.date.issued | 2018 | - |
| dc.identifier.citation | KATONA, Timea, BUDEANU, Razvan-Gabriel, JUGARIU, Anamaria-Romina. Chronic myeloid leukemia associated with early lymphoblastic crisis. In: MedEspera: the 7th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2018, p. 34-35. | en_US |
| dc.identifier.uri | https://medespera.asr.md/wp-content/uploads/Abastract-Book-2018.pdf | - |
| dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/10887 | - |
| dc.description | University of Medicine and Pharmacy of Targu Mures, Romania | en_US |
| dc.description.abstract | Background. The blastic crisis of chronic myeloid leukemia (CML-BC) is usually the final
phase of the disease, in which the percentage of the young, often undifferentiated cells, known as
blastocytes gets above 20%. Nowadays, in the era of the therapy with Tyrosine Kinase
Inhibitors, the transformation from CML to CML-BC occurs much later and more rarely. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | MedEspera | en_US |
| dc.subject | myeloid | en_US |
| dc.subject | leukemia | en_US |
| dc.subject | lymphoblastic | en_US |
| dc.subject | tyrosine | en_US |
| dc.subject | kinase | en_US |
| dc.title | Chronic myeloid leukemia associated with early lymphoblastic crisis | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | MedEspera 2018
|
